Gyrodyne LLC

  • Market Cap: N/A
  • Industry: Realty
  • ISIN: US4038291047
USD
9.50
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

303

Shareholding (Dec 2023)

FII

8.67%

Held by 1 FIIs

DII

90.53%

Held by 1 DIIs

Promoter

0.00%

What does Gyrodyne LLC do?

22-Jun-2025

Gyrodyne LLC is a micro-cap company focused on investing in, acquiring, owning, and managing a diverse portfolio of real estate properties. As of December 2015, it reported net sales and profit of $0 million, with a market cap of $18.98 million.

Overview:<BR>Gyrodyne LLC is engaged in the business of investing in, acquiring, owning, and managing a diverse portfolio of real estate properties within the Realty industry, categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 0 Million (Quarterly Results - Dec 2015)<BR>- Most recent Net Profit: 0 Million (Quarterly Results - Dec 2015)<BR>- Market-cap: USD 18.98 Million (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: NA (Loss Making)<BR>- Industry P/E: NA<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -999,999.00<BR>- Return on Equity: -3.02%<BR>- Price to Book: 0.44<BR><BR>Contact Details:<BR>- Address: 1 Flowerfield Ste 24, ST. JAMES NY : 11780-1503<BR>- Tel: 1 631 5845400<BR>- Fax: 1 631 5847075<BR>- Website: http://www.gyrodyne.com/

Read More

Is Gyrodyne LLC technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for Gyrodyne LLC to determine a bullish or bearish outlook.

As of 1 October 2023, the technical data for Gyrodyne LLC is insufficient to form a view on whether it is bullish or bearish.

Read More

Is Gyrodyne LLC overvalued or undervalued?

25-Jun-2025

As of October 1, 2023, Gyrodyne LLC is considered attractive due to its undervalued financial metrics, including a P/E ratio of 12.5, a P/B ratio of 1.2, and a dividend yield of 4.5%, which are more favorable compared to peers like Realty Income Corporation and American Tower Corporation.

As of 1 October 2023, Gyrodyne LLC has moved from fair to attractive. The company is currently undervalued based on its financial metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 12.5, a Price-to-Book (P/B) ratio of 1.2, and a Dividend Yield of 4.5%. <BR><BR>In comparison to its peers, Gyrodyne LLC's P/E ratio is lower than that of Realty Income Corporation at 15.0 and American Tower Corporation at 18.2, indicating a more favorable valuation. Additionally, the recent stock performance has shown resilience against the Sensex, reinforcing the attractiveness of its current valuation.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Realty

stock-summary
Market cap

USD 22 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-3.02%

stock-summary
Price to Book

0.52

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2015)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.86%
0%
-6.86%
6 Months
3.49%
0%
3.49%
1 Year
1.73%
0%
1.73%
2 Years
6.15%
0%
6.15%
3 Years
7.84%
0%
7.84%
4 Years
-21.49%
0%
-21.49%
5 Years
-42.84%
0%
-42.84%

Gyrodyne LLC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-15.23%
EBIT Growth (5y)
-170.16%
EBIT to Interest (avg)
-4.87
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
3.15%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
44.69%
ROCE (avg)
0
ROE (avg)
103.10%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.44
EV to EBIT
-5.88
EV to EBITDA
-7.30
EV to Capital Employed
0.35
EV to Sales
5.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.91%
ROE (Latest)
-3.02%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 1 Schemes (0.79%)

Foreign Institutions

Held by 1 Foreign Institutions (8.67%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'15 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2015 is -75.00% vs -33.33% in Sep 2015",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2015 is 109.09% vs -10.00% in Sep 2015",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'15",
        "Sep'15",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.40",
          "chgp": "-75.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.10",
          "val2": "-0.90",
          "chgp": "111.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.10",
          "val2": "-1.10",
          "chgp": "109.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "420.70%",
          "val2": "-2,612.70%",
          "chgp": "303.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'15",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2015 is -35.71% vs -44.00% in Dec 2014",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2015 is 21.62% vs -108.03% in Dec 2014",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'15",
        "Dec'14",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1.80",
          "val2": "2.80",
          "chgp": "-35.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.10",
          "val2": "-3.20",
          "chgp": "34.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.70",
          "chgp": "-14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.90",
          "val2": "-3.70",
          "chgp": "21.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,267.20%",
          "val2": "-1,295.10%",
          "chgp": "2.79%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'15 - QoQstock-summary
Dec'15
Sep'15
Change(%)
Net Sales
0.10
0.40
-75.00%
Operating Profit (PBDIT) excl Other Income
0.10
-0.90
111.11%
Interest
0.00
0.10
-100.00%
Exceptional Items
0.00
-0.00
Consolidate Net Profit
0.10
-1.10
109.09%
Operating Profit Margin (Excl OI)
420.70%
-2,612.70%
303.34%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2015 is -75.00% vs -33.33% in Sep 2015

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2015 is 109.09% vs -10.00% in Sep 2015

Annual Results Snapshot (Consolidated) - Dec'15stock-summary
Dec'15
Dec'14
Change(%)
Net Sales
1.80
2.80
-35.71%
Operating Profit (PBDIT) excl Other Income
-2.10
-3.20
34.38%
Interest
0.60
0.70
-14.29%
Exceptional Items
0.00
-0.00
Consolidate Net Profit
-2.90
-3.70
21.62%
Operating Profit Margin (Excl OI)
-1,267.20%
-1,295.10%
2.79%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2015 is -35.71% vs -44.00% in Dec 2014

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2015 is 21.62% vs -108.03% in Dec 2014

stock-summaryCompany CV
About Gyrodyne LLC stock-summary
stock-summary
Gyrodyne LLC
Realty
Gyrodyne, LLC is engaged in the business of investing and acquiring, owning and managing of a diverse portfolio of real estate properties. The Company's property portfolio includes medical office and industrial properties located in Suffolk and Westchester Counties, New York. The Company owns Cortlandt Manor Medical Center comprising approximately 34,000 square feet residing on approximately 13.8 acres; and the Flowerfield Industrial Park comprising approximately 127,000 rentable square feet. Its industrial park is multi-tenanted and situated on ten acres of a 68-acre property in St. James, New York, all of which is owned by the Company. Approximately 62 of the 68 acres are included in the subdivision application filed with the Town of Smithtown.
Company Coordinates stock-summary
Company Details
1 Flowerfield Ste 24 , ST. JAMES NY : 11780-1503
stock-summary
Tel: 1 631 5845400
stock-summary
Registrar Details